20 June 2013
Keywords: earnings, up, teva, strong, generic, sales, israel-based
Article | 24 February 2003
Israel-based drugmaker Teva Pharmaceutical has reported a strongincrease in fourth-quarter earnings on the back of a solid performance
from its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 February 2003
19 June 2013
© 2013 thepharmaletter.com